Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Aug 28, 2024
Open Peer Review Period: Aug 28, 2024 - Oct 23, 2024
Date Accepted: Oct 22, 2025
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Transdiagnostic Cognitive Control Training for Patients Waiting for Outpatient Psychotherapy: Randomized Clinical Trial

Blomberg M, Oberender L, Koster E, Brockmeyer T

Transdiagnostic Cognitive Control Training for Patients Waiting for Outpatient Psychotherapy: Randomized Clinical Trial

JMIR Mhealth Uhealth 2025;13:e65867

DOI: 10.2196/65867

PMID: 41297024

PMCID: 12655892

Transdiagnostic Cognitive Control Training for Patients waiting for Outpatient Psychotherapy: A Randomized Clinical Trial

  • Maximilian Blomberg; 
  • Lisa Oberender; 
  • Ernst Koster; 
  • Timo Brockmeyer

ABSTRACT

Background:

Various mental disorders are associated with impaired cognitive control, which is crucial for effective emotion regulation. Cognitive control training has demonstrated promise in enhancing emotion regulation and alleviating distress in disorders characterized by repetitive negative thinking, such as major depression and anxiety.

Objective:

Given the importance of cognitive control and emotion regulation across mental disorders, this study investigates the efficacy of a mobile cognitive control training in a transdiagnostic outpatient sample waiting for psychotherapy.

Methods:

In this randomized clinical superiority trial with two parallel arms, 80 patients with various mental disorders from a waiting list of an outpatient clinic were allocated to receive either ten sessions of mobile cognitive control training using the Paced Auditory Serial Addition Test (PASAT) or an active control training focusing on response speed. Global mental symptom distress, measured by the Hopkins Symptom Checklist-11 (HSCL-11), served as the primary endpoint. Secondary outcomes included measures of cognitive control, rumination, repetitive negative thinking, difficulties in emotion regulation, cognitive emotion regulation, disorder-specific symptoms, work and social adjustment, and quality of life. Outcomes were measured at baseline, after training and at 3-month and 6-month follow-up.

Results:

Cognitive control training was not superior in primary and most secondary endpoints. As compared to the comparator intervention, it led to greater improvements in cognitive control and, at certain timepoints, in emotion regulation, and symptoms of anxiety.

Conclusions:

This study is the first to assess the efficacy of a mobile cognitive control training using the PASAT in a transdiagnostic outpatient sample. There was no evidence for the training’s efficacy on global mental symptom distress. Potential desirable effects regarding emotion regulation and anxiety symptoms should be investigated in larger studies. Clinical Trial: This study’s design was registered at the German Clinical Trials Register [https://trialsearch.who.int/Trial2.aspx?TrialID=DRKS00024408]


 Citation

Please cite as:

Blomberg M, Oberender L, Koster E, Brockmeyer T

Transdiagnostic Cognitive Control Training for Patients Waiting for Outpatient Psychotherapy: Randomized Clinical Trial

JMIR Mhealth Uhealth 2025;13:e65867

DOI: 10.2196/65867

PMID: 41297024

PMCID: 12655892

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.